Your shopping cart is currently empty

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors, exhibiting EC50 values of 21 µM and 19 µM for GluN1/GluN3A and GluN1/GluN3B receptors, respectively. It specifically enhances the activity of GluN1/GluN3A/B receptors without significantly affecting GluN1/GluN2A-D receptors. UCM-A86 is useful for research on central nervous system diseases.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors, exhibiting EC50 values of 21 µM and 19 µM for GluN1/GluN3A and GluN1/GluN3B receptors, respectively. It specifically enhances the activity of GluN1/GluN3A/B receptors without significantly affecting GluN1/GluN2A-D receptors. UCM-A86 is useful for research on central nervous system diseases. |
| Targets&IC50 | GluN1/3A:21 μM (EC50) |
| Molecular Weight | 338.35 |
| Formula | C15H13F3N4S |
| Cas No. | 1210899-51-6 |
| Smiles | FC(F)(F)C1=NN=C2C=CC(=NN21)SC3=CC=C(C=C3)C(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.